Antibiotice Toekomstige groei
Future criteriumcontroles 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Antibiotice.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
Pharmaceuticals winstgroei | 15.4% |
Inkomstengroei | n/a |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | None |
Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Geen updates
Recent updates
Market Might Still Lack Some Conviction On Antibiotice S.A. (BVB:ATB) Even After 25% Share Price Boost
Jun 07Antibiotice S.A. (BVB:ATB) Looks Just Right With A 26% Price Jump
Jan 30We Think Antibiotice (BVB:ATB) Can Manage Its Debt With Ease
Jan 13These 4 Measures Indicate That Antibiotice (BVB:ATB) Is Using Debt Safely
Aug 16Is Antibiotice (BVB:ATB) A Risky Investment?
Jun 08These 4 Measures Indicate That Antibiotice (BVB:ATB) Is Using Debt Extensively
Mar 10Tread With Caution Around Antibiotice S.A.'s (BVB:ATB) 5.8% Dividend Yield
Feb 11Calculating The Intrinsic Value Of Antibiotice S.A. (BVB:ATB)
Jan 12Are Antibiotice's (BVB:ATB) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 16Is Antibiotice (BVB:ATB) Using Too Much Debt?
Nov 24In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Antibiotice onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
6/30/2024 | 651 | 93 | 36 | 161 | N/A |
3/31/2024 | 619 | 96 | 26 | 128 | N/A |
12/31/2023 | 615 | 81 | 24 | 122 | N/A |
9/30/2023 | 605 | 99 | 15 | 49 | N/A |
6/30/2023 | 572 | 79 | 40 | 71 | N/A |
3/31/2023 | 556 | 65 | 34 | 76 | N/A |
12/31/2022 | 505 | 51 | 71 | 116 | N/A |
9/30/2022 | 498 | 41 | 62 | 137 | N/A |
6/30/2022 | 467 | 45 | 47 | 112 | N/A |
3/31/2022 | 440 | 35 | 47 | 81 | N/A |
12/31/2021 | 379 | 30 | 15 | 44 | N/A |
9/30/2021 | 394 | 27 | 31 | 61 | N/A |
6/30/2021 | 366 | 27 | 26 | 60 | N/A |
3/31/2021 | 342 | 26 | 42 | 81 | N/A |
12/31/2020 | 347 | 26 | 46 | 94 | N/A |
9/30/2020 | 357 | 27 | -5 | 56 | N/A |
6/30/2020 | 370 | 28 | -26 | 45 | N/A |
3/31/2020 | 403 | 32 | -53 | 19 | N/A |
12/31/2019 | 395 | 31 | -49 | 21 | N/A |
9/30/2019 | 371 | 35 | -7 | 61 | N/A |
6/30/2019 | 385 | 37 | -3 | 59 | N/A |
3/31/2019 | 375 | 34 | N/A | N/A | N/A |
12/31/2018 | 369 | 34 | -44 | 21 | N/A |
9/30/2018 | 348 | 34 | N/A | N/A | N/A |
6/30/2018 | 351 | 34 | -46 | 9 | N/A |
3/31/2018 | 344 | 32 | N/A | N/A | N/A |
12/31/2017 | 339 | 34 | N/A | 19 | N/A |
9/30/2017 | 344 | 33 | N/A | N/A | N/A |
6/30/2017 | 341 | 33 | N/A | 28 | N/A |
3/31/2017 | 338 | 29 | N/A | N/A | N/A |
12/31/2016 | 337 | 30 | N/A | 3 | N/A |
9/30/2016 | 343 | 30 | N/A | N/A | N/A |
6/30/2016 | 345 | 28 | N/A | 45 | N/A |
3/31/2016 | 336 | 28 | N/A | N/A | N/A |
12/31/2015 | 334 | 27 | N/A | 60 | N/A |
9/30/2015 | 321 | 25 | N/A | N/A | N/A |
6/30/2015 | 305 | 28 | N/A | 34 | N/A |
3/31/2015 | 314 | 32 | N/A | N/A | N/A |
12/31/2014 | 322 | 31 | N/A | 58 | N/A |
9/30/2014 | 320 | 34 | N/A | N/A | N/A |
6/30/2014 | 327 | 32 | N/A | 51 | N/A |
3/31/2014 | 321 | 32 | N/A | N/A | N/A |
12/31/2013 | 320 | 31 | N/A | 50 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if ATB's forecast earnings growth is above the savings rate (6.2%).
Winst versus markt: Insufficient data to determine if ATB's earnings are forecast to grow faster than the RO market
Hoge groeiwinsten: Insufficient data to determine if ATB's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if ATB's revenue is forecast to grow faster than the RO market.
Hoge groei-inkomsten: Insufficient data to determine if ATB's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if ATB's Return on Equity is forecast to be high in 3 years time